Source:http://linkedlifedata.com/resource/pubmed/id/16432973
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2006-1-25
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0023-9852
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
52
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
156-9
|
| pubmed:dateRevised |
2008-2-15
|
| pubmed:meshHeading |
pubmed-meshheading:16432973-Clinical Trials as Topic,
pubmed-meshheading:16432973-Disease Progression,
pubmed-meshheading:16432973-Dyslipidemias,
pubmed-meshheading:16432973-Humans,
pubmed-meshheading:16432973-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:16432973-Kidney Failure, Chronic,
pubmed-meshheading:16432973-Proteinuria
|
| pubmed:articleTitle |
Dyslipidemia and the risk of end stage renal disease.
|
| pubmed:affiliation |
Renal Medicine and Transplantation Department, Guy's Hospital, London, UK.
|
| pubmed:publicationType |
Journal Article,
Review
|